Article
Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.
Cancer immunology, immunotherapy : CII - 1 Oct 2000
Voutsas I F, Baxevanis C N, Gritzapis A D, Missitzis I, Stathopoulos G P, Archodakis G, Banis C, Voelter W, Papamichail M
Abstract excerpt
Peripheral blood mononuclear cells (PBMC) from cancer patients were cultured in vitro with irradiated autologous tumor cells isolated from malignant effusions (mixed lymphocyte tumor cultures, MLTC) and low-dose (50 IU/ml) recombinant interleukin-2 (IL-2). The combination of IL-2 and prothymosin alpha (ProTalpha) resulted in a greater PBMC-induced response to the autologous tumor than that brought about by IL-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
